Evidence map›Paper›PMID 39705216›Full record

ArticleThe American journal of case reports2024

Howell-Jolly Body-Like Neutrophil Inclusions Following Hematopoietic Stem Cell Transplantation: A Case Report.

Fucun Ma, Mingjian Bai, Xuekai Liu, Guowei Liang

Abstract readCase Reports
In one paragraph

Article in The American journal of case reports, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Fucun MaDepartment of Clinical Laboratory, Aerospace Center Hospital, Beijing, China.
Mingjian BaiDepartment of Clinical Laboratory, Aerospace Center Hospital, Beijing, China.
Xuekai LiuDepartment of Clinical Laboratory, Aerospace Center Hospital, Beijing, China.
Guowei LiangDepartment of Clinical Laboratory, Aerospace Center Hospital, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

BACKGROUND In several studies, the presence of Howell-Jolly body-like inclusions within neutrophils has been observed in cases of HIV infection, SARS-CoV-2 infection, post-transplant immunosuppression, and during chemotherapy or antiviral therapy. The phenomenon of neutrophils exhibiting Howell-Jolly body-like inclusions on peripheral blood smears can be attributable to viral infections or the pharmacological effects of medications. CASE REPORT A 14-year-old male patient who had received a diagnosis of lymphoblastic leukemia a year ago underwent hematopoietic stem cell transplantation and was readmitted due to a recurrence of gastrointestinal graft-versus-host disease (GVHD). During treatment, tacrolimus was administered in conjunction with steroids to treat GVHD, yet the patient's diarrhea worsened. Examination of a peripheral blood smear revealed neutrophils, with cytoplasmic inclusions resembling Howell-Jolly bodies. Despite an increased dosage of tacrolimus, control of GVHD was suboptimal, and there was a risk of gastrointestinal infection. During further treatment, the patient developed symptoms of gastrointestinal bleeding, which, upon gastroscopy and colonoscopy, led to the diagnosis of extensive gastrointestinal mucormycosis. The therapeutic regimen was escalated to include oral amphotericin B, while continuing tacrolimus and discontinuing all other immunosuppressants. CONCLUSIONS The present case highlights the presence of Howell-Jolly body-like inclusions within the cytoplasm of neutrophils observed in the peripheral blood smear of a patient after hematopoietic stem cell transplantation. Morphological analysis suggests that the emergence of these inclusions is highly likely to be induced by medications used in the treatment of GVHD.

Indexed as

Graft vs Host DiseaseHematopoietic Stem Cell TransplantationNeutrophilsAdolescentHumansImmunosuppressive AgentsInclusion BodiesMalePrecursor Cell Lymphoblastic Leukemia-LymphomaTacrolimusImmunosuppressive AgentsTacrolimus

Identifiers

PMID39705216
PMCPMC11668922

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.